Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 332 Neoplasms 221 Prostatic Neoplasms 197 Carcinoma, Non-Small-Cell Lung 156 Lung Neoplasms 134 Pancreatic Neoplasms 118 Colorectal Neoplasms 102 Neoplasm Metastasis 100 Carcinoma, Hepatocellular 96 Leukemia, Myeloid, Acute 94 Multiple Myeloma 91 Brain Neoplasms 89 Lymphoma 86 Head and Neck Neoplasms 76 Melanoma 73 Ovarian Neoplasms 72 Leukemia 71 Leukemia, Lymphocytic, Chronic, B-Cell 69 Glioblastoma 69 Precursor Cell Lymphoblastic Leukemia-Lymphoma 66 Colonic Neoplasms 61 Recurrence 59 Lymphoma, Non-Hodgkin 54 Rectal Neoplasms 50 Hematologic Neoplasms 50 Lymphoma, Follicular 49 Glioma 49 Squamous Cell Carcinoma of Head and Neck 47 Lymphoma, Large B-Cell, Diffuse 47 Carcinoma, Renal Cell 46

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × Resectable Non-Small Cell Lung Cancer × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡